AstraZeneca puts Major COVID-19 vaccine trial hold over Security concern

The analysis is examining a COVID-19 vaccine being developed by AstraZeneca and University of Oxford researchers in different websites, such as the United Kingdom, in which the disease has been reported. The character of this case and if it occurred weren’t detailed, even though the player is expected to recover, based on standards that are contentious, which reported that the trial was halted because of”suspected severe adverse reaction”